
Chem p. 1183 - 1189 (2020)
Update date:2022-08-30
Topics:
Bauer, Sophie
Berger, Martin
Knittl-Frank, Christian
Maulide, Nuno
Winter, Georg
Although clinical applications of abundant feedstock triterpenoids such as oleanolic acid are limited because of poor solubility and bioavailability, synthetic access to higher hydroxylated oleanane terpenoids is challenging. We now report the use of relay C?H oxidation logic to mimic the processes carried out in nature by P450 monooxygenase enzymes. To this end, we used the C-23-OH as natural handle for a hydrogen-atom transfer to access C-6, enabling the first syntheses of highly oxidized natural products uncargenin C and protobassic acid as well as uncovering the anti-leukemic activity of a synthetic intermediate. Chemical modification of readily available, scarcely oxidized natural products not only enables access to higher and more valuable congeners but can also pave the way to pharmaceutically relevant derivatives with enhanced properties. Achieving site-selective oxidation of such natural products is an endeavor often controlled by the presence of directing elements. Because of this fact, the oxidation of C?H bonds remote from such elements is either unfeasible or requires more elaborate synthetic strategies. We report the use of relay C?H oxidation as a concept to achieve the oxidation of previously inaccessible ring B in the abundant feedstock oleanolic acid. This resulted not only in the first total synthesis of a number of polyhydroxylated natural triterpenoids but also revealed an anti-leukemic intermediate. The strategy presented here could become a very general approach in the synthesis of valuable triterpenoids. Although biological applications of abundant feedstock triterpenoids such as oleanolic acid are limited because of poor solubility, synthetic access to higher hydroxylated metabolites is challenging. We use relay C?H oxidation logic to mimic the processes carried out in Nature by P450 monooxygenase enzymes. To this end, we use the C-23-OH as natural handle for a hydrogen-atom-transfer access to C-6, enabling the first syntheses of highly oxidized natural products as well as uncovering the anti-leukemic activity of a synthetic intermediate.
Contact:+86-371-67759225
Address:No.32, Jinsuo Road, High-tech Zone
Shanghai Yurui Biotechnology(Anyang) Pharmaceutical Co., Ltd
Contact:+86-0372-3662335 +86-0372-3661988
Address:hanling industrial park anyang
Dalian Synco Chemical Co., Ltd.
Contact:+86-411-83635150
Address:Rm 1004, 24, Tangshan Street, Dalian
Melone Pharmaceutical Co., ltd
Contact:+86-411 82593920, 82593631
Address:No 232, JInma Roda, Development Zone, Dalian, China
Zibo Ocean International Trade Co.,Ltd(expird)
Contact:+86 533 5160706
Address:1117, Hongtai Bld., Songling rd, Zichuan,Zibo,Shandong,China
Doi:10.7164/antibiotics.26.284
(1973)Doi:10.1021/jm990286m
(1999)Doi:10.1039/c5ra12960e
(2015)Doi:10.1080/10641190009353789
(1938)Doi:10.1007/s00706-019-02504-5
(2019)Doi:10.1039/jr9270000588
(1927)